Source:http://linkedlifedata.com/resource/pubmed/id/11093069
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2001-2-5
|
pubmed:abstractText |
In 12 patients with affective disorders (ICD-10: F31, F32, F33), EEGs were recorded before and after 4.4 months of lithium treatment. Effects of lithium on the EEG were analyzed by power spectral analysis controlled for vigilance. We found (1) an increase in relative power in both delta and theta band which was related to the lithium plasma level, (2) a decrease in relative alpha power especially at occipital leads and (3) a reduction of the dominant alpha frequency. The changes in relative power were more pronounced in the right hemisphere, which is in contrast to the hypothesis of a site-specific localization of lithium effects only in left anterior regions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0302-282X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 S. Karger AG, Basel.
|
pubmed:issnType |
Print
|
pubmed:volume |
42 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11093069-Aged,
pubmed-meshheading:11093069-Antimanic Agents,
pubmed-meshheading:11093069-Arousal,
pubmed-meshheading:11093069-Electroencephalography,
pubmed-meshheading:11093069-Female,
pubmed-meshheading:11093069-Fourier Analysis,
pubmed-meshheading:11093069-Functional Laterality,
pubmed-meshheading:11093069-Humans,
pubmed-meshheading:11093069-Lithium,
pubmed-meshheading:11093069-Male,
pubmed-meshheading:11093069-Middle Aged,
pubmed-meshheading:11093069-Mood Disorders
|
pubmed:year |
2000
|
pubmed:articleTitle |
Lithium-induced EEG changes in patients with affective disorders.
|
pubmed:affiliation |
Section of Neurophysiology and Outpatient Clinic for Relapse Prophylaxis in Affective Disorders, Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|